Sympathetic neural responses to smoking are age dependent

Journal of Hypertension

Volumn 24, Issue 4, 2006, Pages 691-695

  Hering, Dagmara ^a   Somers, Virend K ^b   Kara, Tomas ^b   Kucharska, Wiestawa ^a   Jurak, Pavel ^b   Bieniaszewski, Leszek ^a   Narkiewicz, Krzysztof ^a,b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MAYO CLINIC   (United States)

Author keywords

Age; Cardiovascular disease; Heart rate; Smoking; Sympathetic nervous system

Indexed keywords

ADRENERGIC SYSTEM; ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; RISK FACTOR; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION;

EID: 33645530603     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000217851.95583.57     Document Type: Article

References (21)

1. Kannel W, Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens 1990; 8 (suppl 5): S3-S5.
2. Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J 1988; 115:242-249.
3. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 1986; 314:271-275.
4. Gabbay FH, Krantz DS, Kop WJ, Hedges SM, Klein J, Gottdioener JS. Triggers of myocardial ischemia during daily life in patients with coronary artery disease: physical and mental activity, anger and smoking. J Am Coll Cardiol 1996; 27:585-592.
5. Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 1997; 336:755-761.
6. Kannel WB, McGee DL, Castelli WP. Latest perspectives on cigarette smoking and cardiovascular disease: the Framingham study. J Cardiac Rehabil 1984; 4:267-277.
7. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994; 90:248-253.
8. Niedermaier ON, Smith ML, Beightol LA, Zukowska-Grojec Z, Goldstein DS, Eckberg DL. Influence of cigarette smoking on human autonomic function. Circulation 1993; 88:562-571.
9. Narkiewicz K, van de Borne PJH. Hausberg M, Cooley RL, Winniford MD, Somers VK. Cigarette smoking increases sympathetic outflow. Circulation 1998; 98:528-534.
10. Chapleau MW, Cunningham JT, Sullivan MJ, Wachtel RE, Abboud FM. Structural versus functional modulation of the arterial baroreflex. Hypertension 1995; 26:341-347.
11. Seals DR, Dinenno FA. Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging. Am J Physiol Heart Circ Physiol 2004; 287:H1895-H1905.
12. Kilpatrick DL, Slepetis R, Kirshner N. Ion channels and membrane potential in stimulus-secretion coupling in adrenal medulla cells. J Neurochem 1981; 36:1245-1255.
13. Su C, Bevan JA. Blockade of the nicotine-induced norepinephrine release by cocaine, phenoxybenzamine and desipramine. J Pharmacol Exp Ther 1970; 175:533-540.
14. Krüger C, Haunstetter A, Gerber S, Serf C, Kaufmann A, Kübner W, Haass M. Nicotine-induced exocytotic norepinephrine release in guinea-pig heart, human atrium and bovine adrenal chromaffin cells: modulation by single components of ischaemia. J Mol Cell Cardiol 1995; 27:1491-1506.
15. Lauer MS, Pashkow FJ, Larson MG, Levy D. Association of cigarette smoking with chronotropic incompetence and prognosis in the Framingham Heart Study. Circulation 1997; 96:897-903.
16. Eckberg DL, Rea RF, Andersson OK, Hedner T, Pernow J, Lundberg JM, Wallin BG. Baroreflex modulation of sympathetic activity and sympathetic neuroatransmitters in humans. Acta Physiol Scand 1988; 133:221-231.
17. Dietz R, Schömig A, Kusterer K, Dart AM, Kübler W. Vasopressor systems during smoking in humans. Klin Wochenschr 1984; 62 (suppl II):11-17.
18. Hayano J, Yamada M, Sakakibara Y, Fujinami T, Yokohama K, Watanabe Y, Takata K. Short- and long-term effects of cigarette smoking on heart rate variability. Am J Cardiol 1990; 65:84-88.
19. Grassi G, Bolla G, Seravalle G, Turri C, Lanfranchi A, Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci 1997; 92:285-289.
20. Niskanen L, Laaksonen DE, Nyyssönen K, Punnonen K, Valkonen VP, Fuentes R, et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004; 44:859-865.
21. Julius S, Nesbitt S. Sympathetic overactivity in hypertension. A moving target. Am J Hypertens 1996; 9:113S-120S.